失眠的评估与管理:最新进展
本文综述失眠的评估要点与治疗选择,涵盖失眠认知行为治疗及多种药物(苯二氮䓬类、Z药、褪黑素受体激动剂、选择性组胺H1拮抗剂、食欲素拮抗剂、抗抑郁药、抗精神病药、抗惊厥药、非选择性抗组胺药)。综述指出部分常用失眠疗法缺乏严格双盲随机对照试验,但已有多种干预在具备上述特征的试验中显示疗效且风险获益特征明确,可作为临床系统循证治疗基础。
要点
- 失眠与功能损害、生活质量下降及精神躯体疾病相关,需提供有效治疗。
- 非药物治疗以失眠认知行为治疗最为突出,药物治疗选择多样。
- 部分常用失眠疗法缺乏严格双盲随机对照试验,需更多研究。
核心结论
- 已有多种干预在严格双盲随机对照试验中显示对失眠有疗效且风险获益特征明确,可构成临床系统循证治疗的基础。
- 部分最常使用的失眠疗法仍缺乏严格双盲随机对照试验。
研究设计与样本
- 本文为综述,回顾失眠评估的关键方面及可用治疗选择,并审查相关研究证据。
主要发现
- 失眠是常见疾病,与功能和生活质量显著损害、精神与躯体疾病及事故相关。
- 非药物治疗中最突出的是失眠认知行为治疗。
- 药物治疗包括苯二氮䓬类、Z药、褪黑素受体激动剂、选择性组胺H1拮抗剂、食欲素拮抗剂、抗抑郁药、抗精神病药、抗惊厥药和非选择性抗组胺药。
- 部分最常使用的失眠疗法缺乏严格双盲随机对照试验。
关键数值与推荐
- 多种干预在严格双盲随机对照试验中显示对失眠有治疗效应,且风险获益特征已明确。
- 部分常用失眠疗法缺乏严格双盲随机对照试验。
临床怎么用
- 临床可基于已有证据对失眠进行系统、循证的治疗。
- 非药物治疗中可考虑失眠认知行为治疗,药物治疗需根据可用证据选择。
局限性
- 部分最常使用的失眠疗法缺乏严格双盲随机对照试验,需更多研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Insomnia poses significant challenges to public health. It is a common condition associated with marked impairment in function and quality of life, psychiatric and physical morbidity, and accidents. As such, it is important that effective treatment is provided in clinical practice. To this end, this paper reviews critical aspects of the assessment of insomnia and the available treatment options. These options include both non-medication treatments, most notably cognitive behavioral therapy for insomnia, and a variety of pharmacologic therapies such as benzodiazepines, "z-drugs", melatonin receptor agonists, selective histamine H1 antagonists, orexin antagonists, antidepressants, antipsychotics, anticonvulsants, and non-selective antihistamines. A review of the available research indicates that rigorous double-blind, randomized, controlled trials are lacking for some of the most commonly administered insomnia therapies. However, there are an array of interventions which have been demonstrated to have therapeutic effects in insomnia in trials with the above features, and whose risk/benefit profiles have been well characterized. These interventions can form the basis for systematic, evidence-based treatment of insomnia in clinical practice. We review this evidence base and highlight areas where more studies are needed, with the aim of providing a resource for improving the clinical management of the many patients with insomnia.
引用
- Krystal AD, Prather AA, Ashbrook LH, et al. The assessment and management of insomnia: an update. World Psychiatry. 2019. PMID: 31496087. doi:10.1002/wps.20674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。